Literature DB >> 34956459

Up-regulation of TUG1 can regulate miR-494/PDK4 axis to inhibit LPS-induced acute lung injury caused by sepsis.

Lin Yang1, Li Zhao1, Hui Zhang1, Peili Chen1.   

Abstract

BACKGROUND: Acute lung injury (ALI) caused by sepsis is the most common disease and the leading cause of death in intensive care units. Recent studies have revealed that long non-coding RNAs (LncRNAs) are abnormally expressed in sepsis. This study aimed to clarify the role and mechanism of Taurine up-regulated gene 1 (TUG1) in ALI caused by sepsis.
METHODS: Lipopolysaccharide (LPS) was used to simulate sepsis-induced ALI model. RT-PCR, Dual luciferase reporter (DLR) assay and RNA immunoprecipitation (RIP) were used to detect TUG1 and miR-494. The rat model with sepsis-induced ALI was established by intraperitoneal injection of LPS to verify the results of in vitro experiments.
RESULTS: The expressions of TUG1 and PDK4 were down-regulated while the expression of miR-494 was up-regulated in lung tissues and human small airway epithelial cells (HSAECs). TUG1 was indirectly mediated. Overexpression of TUG1 or inhibition of miR-494 could significantly improve the survival rate of HSAECs. Transfection of miR-494 mimics achieved the opposite effect. Enzyme-linked immunosorbent assay (ELISA) showed that the expression of arthritis-related factors in rats was increased after up-regulating TUG1.
CONCLUSION: TUG1 is lowly expressed in sepsis. Up-regulating TUG1 can alleviate the inflammatory response in ALI caused by LPS-induced sepsis, which may be a clinical treatment target. AJTR
Copyright © 2021.

Entities:  

Keywords:  PDK4; acute lung injury; lncRNA TUG1; miR-494; sepsis

Year:  2021        PMID: 34956459      PMCID: PMC8661222     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  36 in total

1.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels.

Authors:  Bo-Yoon Park; Jae-Han Jeon; Younghoon Go; Hye Jin Ham; Jeong-Eun Kim; Eun Kyung Yoo; Woong Hee Kwon; Nam-Ho Jeoung; Yong Hyun Jeon; Seung-Hoi Koo; Byung-Gyu Kim; Ling He; Keun-Gyu Park; Robert A Harris; In-Kyu Lee
Journal:  Diabetes       Date:  2018-07-31       Impact factor: 9.461

3.  Autophagy Activation Improves Lung Injury and Inflammation in Sepsis.

Authors:  Hongying Zhao; Hongguang Chen; Meng Xiaoyin; Guotao Yang; Ying Hu; Keliang Xie; Yonghao Yu
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

4.  Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the Jun N-Terminal Kinase (JNK) pathway in C2C12 cells.

Authors:  Hana Park; Nam Ho Jeoung
Journal:  Biochem Biophys Res Commun       Date:  2015-12-29       Impact factor: 3.575

Review 5.  Sepsis in Older Adults.

Authors:  Theresa A Rowe; June M McKoy
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

6.  LncRNA TUG1 reverses LPS-induced cell apoptosis and inflammation of macrophage via targeting MiR-221-3p/SPRED2 axis.

Authors:  Lili Hu; Hongwei Ye; Jianjun Liao
Journal:  Biosci Biotechnol Biochem       Date:  2020-08-25       Impact factor: 2.043

7.  The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation.

Authors:  Meng Du; Lin Yuan; Xin Tan; Dandan Huang; Xiaojing Wang; Zhe Zheng; Xiaoxiang Mao; Xiangrao Li; Liu Yang; Kun Huang; Fengxiao Zhang; Yan Wang; Xi Luo; Dan Huang; Kai Huang
Journal:  Nat Commun       Date:  2017-12-11       Impact factor: 14.919

8.  The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation.

Authors:  Ding-Wen Cao; Man-Man Liu; Rui Duan; Yi-Fu Tao; Jun-Shan Zhou; Wei-Rong Fang; Jun-Rong Zhu; Li Niu; Jian-Guo Sun
Journal:  Acta Pharmacol Sin       Date:  2019-08-20       Impact factor: 6.150

9.  Downregulation of lncRNA TUG1 attenuates inflammation and apoptosis of renal tubular epithelial cell induced by ischemia-reperfusion by sponging miR-449b-5p via targeting HMGB1 and MMP2.

Authors:  Yuan Xu; Yulin Niu; Haiyang Li; Guanghui Pan
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657

10.  Long noncoding RNA TUG1 is downregulated in sepsis and may sponge miR-27a to downregulate tumor necrosis factor-α.

Authors:  Li Wang; Qinghua Zhong; Yanli Feng; Xiaoying Tang; Qiong Wang; Yongyi Zou; Jiang Duan
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

View more
  4 in total

1.  Diagnostic and Prognostic Value of Deregulated Circulating Long Non-coding RNA TUG1 in Elderly Patients with Severe Pneumonia.

Authors:  Kai Gong; Jiao Xu; Jianlei Tang
Journal:  Inflammation       Date:  2022-09-15       Impact factor: 4.657

Review 2.  Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure.

Authors:  Domenico Di Raimondo; Edoardo Pirera; Giuliana Rizzo; Irene Simonetta; Gaia Musiari; Antonino Tuttolomondo
Journal:  Diagnostics (Basel)       Date:  2022-05-31

3.  LncRNA NEAT1 Potentiates SREBP2 Activity to Promote Inflammatory Macrophage Activation and Limit Hantaan Virus Propagation.

Authors:  Yongheng Yang; Mengyun Li; Yongtao Ma; Wei Ye; Yue Si; Xuyang Zheng; He Liu; Linfeng Cheng; Liang Zhang; Hui Zhang; Xijing Zhang; Yingfeng Lei; Lixin Shen; Fanglin Zhang; Hongwei Ma
Journal:  Front Microbiol       Date:  2022-04-13       Impact factor: 6.064

4.  Evaluating the potency of blood long noncoding RNA PVT1 as candidate biomarker reflecting inflammation, multiple organ dysfunction, and mortality risk in sepsis patients.

Authors:  Jing Chen; Haibo Ren; Bo Liu
Journal:  J Clin Lab Anal       Date:  2022-02-04       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.